Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the safety and immunogenicity of a virus-like particle polio vaccine in infants and toddlers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• VLP-Polio (virus-like particle polio vaccine)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Poliomyelitis | Phase 1, Phase 2 | Status: RECRUITING